Taysha Gene Therapies, Inc.
TSHA · Healthcare · $1.6B
$4.87-2.40%
Price
$6.53
$4.99
Jul 2, 26Sep 29, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue$1M
6/'26 vs prev quarter
Company Health
Market Cap$1.6B
Operating Margin-2792.3%
Cash on Hand$455M29.2% of market cap
Free Cash Flow$-136M-8.7% of market cap
Among 327 Biotechnology peers
LowMedianHigh
PSR284.0xmedian 11.4xPBR4.0xmedian 2.0xROE-38.6%median -54.5%
